Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,030,900 | 862,800 | 1,506,900 | 1,312,800 | 1,174,200 |
| Marketable Securities | 465,000 | 604,000 | 287,800 | 248,400 | 156,400 |
| Receivables | 686,200 | 664,900 | 664,200 | 700,300 | 664,300 |
| Inventories | 730,600 | 726,700 | 737,800 | 759,500 | 767,900 |
| Other current assets | 234,500 | 237,100 | 241,900 | 233,300 | 229,100 |
| TOTAL | $3,241,300 | $3,180,700 | $3,515,500 | $3,322,900 | $3,069,200 |
| Non-Current Assets | |||||
| PPE Net | 1,552,200 | 1,546,600 | 1,464,600 | 1,445,800 | 1,417,900 |
| Investments And Advances | 1,623,700 | 1,834,200 | 1,282,000 | 1,014,200 | 802,200 |
| Intangibles | 1,488,300 | 1,491,500 | 1,495,700 | 1,498,800 | 1,501,100 |
| Other Non-Current Assets | 514,400 | 449,600 | 402,500 | 380,400 | 423,300 |
| TOTAL | $5,178,600 | $5,321,900 | $4,644,800 | $4,339,200 | $4,144,500 |
| Total Assets | $8,419,900 | $8,502,600 | $8,160,300 | $7,662,100 | $7,213,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 158,800 | 204,500 | 139,500 | 861,100 | 772,500 |
| Accrued Expenses | 767,200 | 802,300 | 802,800 | N/A | N/A |
| TOTAL | $949,900 | $1,032,300 | $966,500 | $886,200 | $799,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 595,900 | 595,700 | 595,500 | 595,400 | 595,200 |
| aiOther Non-Current Liabilities | 1,029,200 | 1,038,700 | 1,057,000 | 1,047,200 | 1,161,100 |
| TOTAL | $1,625,100 | $1,634,400 | $1,652,500 | $1,642,600 | $1,756,300 |
| Total Liabilities | $2,575,000 | $2,666,700 | $2,619,000 | $2,528,800 | $2,555,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 621,752 | 623,207 | 624,335 | 623,328 | 621,637 |
| Common Shares | 642,900 | 642,000 | 641,200 | 640,100 | 637,500 |
| Retained earnings | 6,441,700 | 6,068,100 | 5,732,800 | 5,392,700 | 4,903,200 |
| Other shareholders' equity | -186,100 | -157,600 | -155,800 | -159,200 | -172,100 |
| TOTAL | $5,844,900 | $5,835,900 | $5,541,300 | $5,133,300 | $4,658,400 |
| Total Liabilities And Equity | $8,419,900 | $8,502,600 | $8,160,300 | $7,662,100 | $7,213,700 |